We had several financings that didnt make the 11/14 edition of Vital Signs.

VectorY Therapeutics – a biotech company developing antibody therapies to treat neurodegenerative diseases, raised a $138M Series A. (Amsterdam, Netherlands)

Needed – a company that develops nutrition products for prenatal care, raised $14M. (LA, CA)